Author: Healthcare Propulsion Staff

Climate change is often discussed in terms of rising temperatures, extreme weather and environmental loss. But there’s another consequence that can be harder to see: The impact on our mental health.In this exclusive video, we explore how heat exposure influences mental state, drawing on research by Kim Meidebauers, a neuroscientist at Washington State University who studies the effect of heat on emotion and behavior.Burning up: How can we adapt to a warming world?As the planet warms, our environment will be transformed, but so will our bodies. This video is part of a series where we investigate the health impacts of…

Read More

Patients with metastatic non-small cell lung cancer (NSCLC) harboring class II and class III BRAF alterations have distinct clinicopathologic and genomic characteristics, with class III alterations potentially associated with worse prognosis, according to research presented today at the International Association for the Study of Lung Cancer (IASLC) 2026 World Conference on Lung Cancer (WCLC). The study, “Characteristics and outcomes to immunotherapy in patients with NSCLC harboring class II and III BRAF alterations,” examined outcomes with first-line immune checkpoint inhibitors (ICI) and genomic features in patients with these less well-defined BRAF alterations. Approximately 4% of patients with NSCLC harbor BRAF alterations.…

Read More

A large-scale, federally funded quality improvement program developed in collaboration with infection prevention experts at the Johns Hopkins Armstrong Institute for Patient Safety and Quality was associated with a 65% reduction in hospital-onset bloodstream infections caused by methicillin-resistant Staphylococcus aureus (MRSA) among participating hospital units. The findings, published Aug. 27 in JAMA Network Open, suggest that a comprehensive approach to putting existing infection prevention evidence into everyday practice can substantially reduce infections among hospitalized patients. The Agency for Healthcare Research and Quality (AHRQ) Safety Program for MRSA Prevention was implemented in 106 intensive care units (ICUs) and 87 non-ICUs at 94 hospitals across the…

Read More

Mobile low-dose computed tomography (LDCT) screening can reach high-risk and socially vulnerable populations in resource-limited settings, according to initial results from the Third Brazilian Early Lung Cancer Trial (BRELT3) presented at the International Association for the Study of Lung Cancer (IASLC) 2026 World Conference on Lung Cancer (WCLC). BRELT3 expanded lung cancer screening through a mobile CT unit across four cities in Northeast Brazil from 2023 to 2025. The prospective, single-arm observational study focused on individuals ages 50 to 80 who were current or former smokers and used both media campaigns and active outreach by trained community health workers to…

Read More

Patients with metastatic squamous non-small cell lung cancer (NSCLC) whose disease progressed following PD-(L)1 inhibitor therapy experienced a median overall survival of 18.5 months with the investigational anti-CTLA-4 antibody gotistobart compared with 10.0 months for patients receiving docetaxel, according to updated findings from Stage 1 of the Phase 3 PRESERVE-003 trial. These results were presented today at the International Association for the Study of Lung Cancer (IASLC) 2026 World Conference on Lung Cancer (WCLC) in Seoul, Republic of Korea. The updated analysis demonstrated a 43% reduction in the risk of death (HR = 0.572) and confirmed a safety profile consistent…

Read More

Check out today’s featured companies who have recently raised a round of funding, and be sure to check out the full list of past healthcare IT fundings. Verily Health Secures New Investment From NVIDIA and CU Healthcare Innovation Fund Investment Supports the Next Phase of Verily’s Precision Health AI Strategy Verily Health Inc. today announced it has received investment support from NVIDIA, as Verily extends its March fundraising. Existing investor CU Healthcare Innovation Fund II, LP is also making an additional investment. Verily’s current investors include Alphabet, Series X Capital, UCHealth, and others. “We are pleased to welcome NVIDIA as…

Read More

Infection can develop in up to 10-20% of patients after a Cesarean delivery, and the risk nearly doubles for those who have an unplanned cesarean delivery, such as those performed during labor. In 2016, researchers published the results of a double-blind, randomized clinical trial of patients undergoing an emergency c-section in which half of participants received intravenous azithromycin in addition to routine antibiotics. Compared to those in the placebo group, those in the azithromycin group had a 50% lower rate of infections (12% versus 6%). But the extent to which the trial’s results have since changed clinical practice has been…

Read More

A newly proposed International Association for the Study of Lung Cancer (IASLC) tumor budding-based grading system successfully identified patients with resected lung squamous cell carcinoma (SqCC) at higher risk of poor outcomes and showed potential to help guide selection for adjuvant chemotherapy, according to research presented at the IASLC 2026 World Conference on Lung Cancer on Lung Cancer. (WCLC). The study independently validated the 2025 IASLC two-tier grading system, which classifies resected lung SqCC as low grade or high grade based solely on tumor budding. Investigators retrospectively reviewed 585 consecutive patients who underwent curative-intent upfront resection at Yonsei University Medical…

Read More

New diagnoses of cannabis use disorder (CUD) among adolescents in Northern California began climbing after recreational cannabis was legalized in California in 2016, reversing a steady decline in the three years prior, according to a new study published in the journal Addiction. The researchers say their findings call for disorder-level outcomes to be tracked alongside standard measures of use prevalence and frequency when evaluating the public health effects of cannabis legalization. Most surveys of adolescent cannabis use tell us how many teens have tried cannabis, but don’t tell us how many are developing a disorder that brings them into…

Read More